Refine by
Diabetic Complications Articles & Analysis
38 news found
Data from pivotal PHOTON trial demonstrate long term efficacy of aflibercept 8 mg with extended intervals comparable to Eylea (aflibercept 2 mg) at fixed 8-weekly dosing over two years Patients assigned to a 16-week dosing regimen at baseline received a mean of 7.8 injections (6 fewer than Eylea) Safety profile of aflibercept 8 mg in diabetic macular edema (DME) remains ...
ByBayer AG
“Despite progress in risk reduction in type 2 diabetes, chronic kidney disease in type 1 diabetes remains understudied, leaving a huge unmet need to reduce the risks of end-stage kidney disease and cardiovascular events. ...
ByBayer AG
Aflibercept 8 mg was investigated in neovascular (wet) age-related macular degeneration (PULSAR) and diabetic macular edema (PHOTON) to evaluate efficacy and safety compared to Eylea (aflibercept 2 mg). ...
ByBayer AG
CKD is one of the most frequent complications arising from diabetes and is also an independent risk factor of cardiovascular disease. ...
ByBayer AG
Aflibercept 8 mg was investigated in neovascular (wet) age-related macular degeneration (PULSAR) and diabetic macular edema (PHOTON) to evaluate efficacy and safety compared to Eylea (aflibercept 2 mg). ...
ByBayer AG
“Patients with chronic kidney disease are faced with an increased risk of cardiovascular events,” said Professor Peter Rossing, Head of Complications Research at the Steno Diabetes Center Copenhagen. “As chronic kidney disease progresses silently, with oftentimes no symptoms in the early stages, patients with type 2 diabetes ...
ByBayer AG
Aflibercept 8 mg was investigated in neovascular (wet) age-related macular degeneration (PULSAR) and diabetic macular edema (PHOTON) to evaluate efficacy and safety compared to Eylea (aflibercept 2 mg). ...
ByBayer AG
“As patients are faced with an increased risk of cardiovascular events already in early stages of chronic kidney disease and type 2 diabetes, and as this risk is growing with kidney health decline, timely diagnosis and treatment is crucial to limit disease progression and to potentially prevent cardiovascular complications and mortality,” said ...
ByBayer AG
“Peripheral CB1 blockade has the potential to address the significant unmet medical need in DKD as well as other complications of diabetes and obesity.” “We’re excited about the progress of our INV-202 program that represents a novel, orally administered option for treating metabolic conditions,” said François Ravenelle, PhD, ...
These data underscore how managing diabetes can be an overwhelming task that can challenge even the most motivated person living with diabetes,” said Dr. ...
ByLifeScan
“Eylea is a high impact therapy based on scientific innovation – an amazing story and remains the global standard of care for age-related macular degeneration and diabetic macular edema and the evidence for aflibercept 8 mg can support us in further relieving the burden for patients and healthcare providers,” said Dr. ...
ByBayer AG
According to the results of a World Health Organization survey released in June 2020, there was a 53% service disruption for hypertension treatment, 49% disruption for the treatment of diabetes and related complications, 42% disruption for cancer treatment and 31% disruption for cardiovascular emergencies. ...
CKD is one of the most frequent complications arising from diabetes and is also an independent risk factor of cardiovascular disease. ...
ByBayer AG
Such a study presents an opportunity to evaluate a comprehensive set of biomarker data in DKD that may also be relevant to a broad landscape of diabetic-related indications, including cardiometabolic and fibrotic complications. ...
Patients living with chronic kidney disease associated with type 2 diabetes are three times more likely to die from a cardiovascular event than those with type 2 diabetes alone. ...
ByBayer AG
Adults between the ages of 18 and 60 years with morbid obesity (BMI of > 40) or severe obesity (BMI of > 35) with at least one complication (diabetes, hypertension, sleep apnea syndrome, joint disorders) People who have already tried to lose weight without success despite receiving specialized medical care for several months (dietary monitoring, physical ...
Additionally, diabetic retinopathy, the most feared complication of diabetes and the primary overall cause of blindness from any disease, has a prevalence from 19.7 percent to 44.7 percent in Saudi Arabia. ...
China is the country with the largest number of adults with diabetes, with an estimated 140 million people living with diabetes and a further estimated 73 million people with undiagnosed diabetes. ...
ByBayer AG
Army, President and Chairman of MTEC Board commented on the importance of Microbion’s research. “Though diabetic foot ulcer infections aren’t traditionally thought of as a combat related wound suffered in the field, diabetes is a serious disease that affects a significantly high percentage of our veterans and its complications ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced three abstracts, including two oral presentations and one poster, detailing data on type 1 diabetes (T1D) and its Phase 1/2 trial of VX-880, a stem cell-derived, fully differentiated pancreatic islet cell replacement therapy, have been accepted for presentation during the American Diabetes ...